Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib versus naproxen effects on blood pressure in pediatric juvenile idiopathic arthritis
2014-003737-26Phase 3
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in juvenile idiopathic arthritis (JIA) comparing Celebrex arm with Naproxen arm (2 arms). Primary endpoint: Change from baseline to Week 6/final visit in systolic blood pressure.
02
Drugs
celecoxibnaproxen
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2014-003737-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003737-26.